Literature DB >> 31727539

Novel ATAD3A recessive mutation associated to fatal cerebellar hypoplasia with multiorgan involvement and mitochondrial structural abnormalities.

Susana Peralta1, Adrián González-Quintana2, Marta Ybarra3, Aitor Delmiro2, Rafael Pérez-Pérez1, Jorge Docampo2, Joaquín Arenas2, Alberto Blázquez2, Cristina Ugalde4, Miguel A Martín2.   

Abstract

Lethal neonatal encephalopathies are heterogeneous congenital disorders that can be caused by mitochondrial dysfunction. Biallelic large deletions in the contiguous ATAD3B and ATAD3A genes, encoding mitochondrial inner membrane ATPases of unknown function, as well as compound heterozygous nonsense and missense mutations in the ATAD3A gene have been recently associated with fatal neonatal cerebellar hypoplasia. In this work, whole exome sequencing (WES) identified the novel homozygous variant c.1217 T > G in ATAD3A, predicting a p.(Leu406Arg) substitution, in four siblings from a consanguineous family presenting with fatal neonatal cerebellar hypoplasia, seizures, axial hypotonia, hypertrophic cardiomyopathy, hepatomegaly, congenital cataract, and dysmorphic facies. Biochemical phenotypes of the patients included hyperlactatemia and hypocholesterolemia. Healthy siblings and parents were heterozygous for this variant, which is predicted to introduce a polar chain within the catalytic domain of ATAD3A that shortens its beta-sheet structure, presumably affecting protein stability. Accordingly, patient's fibroblasts with the homozygous variant displayed a specific reduction in ATAD3A protein levels associated with profound ultrastructural alterations of mitochondrial cristae and morphology. Our findings exclude the causative role of ATAD3B on this severe phenotype, expand the phenotypical spectrum of ATAD3A pathogenic variants and emphasize the vital role of ATAD3A in mitochondrial biogenesis.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ATAD3A; Cerebellar hypoplasia; Fatal neonatal encephalopathy; Missense homozygous; Mitochondrial disorder; Mitochondrial ultrastructural alterations

Mesh:

Substances:

Year:  2019        PMID: 31727539     DOI: 10.1016/j.ymgme.2019.10.012

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  7 in total

1.  Fatal perinatal mitochondrial cardiac failure caused by recurrent de novo duplications in the ATAD3 locus.

Authors:  Ann E Frazier; Alison G Compton; Yoshihito Kishita; Daniella H Hock; AnneMarie E Welch; Sumudu S C Amarasekera; Rocio Rius; Luke E Formosa; Atsuko Imai-Okazaki; David Francis; Min Wang; Nicole J Lake; Simone Tregoning; Jafar S Jabbari; Alexis Lucattini; Kazuhiro R Nitta; Akira Ohtake; Kei Murayama; David J Amor; George McGillivray; Flora Y Wong; Marjo S van der Knaap; R Jeroen Vermeulen; Esko J Wiltshire; Janice M Fletcher; Barry Lewis; Gareth Baynam; Carolyn Ellaway; Shanti Balasubramaniam; Kaustuv Bhattacharya; Mary-Louise Freckmann; Susan Arbuckle; Michael Rodriguez; Ryan J Taft; Simon Sadedin; Mark J Cowley; André E Minoche; Sarah E Calvo; Vamsi K Mootha; Michael T Ryan; Yasushi Okazaki; David A Stroud; Cas Simons; John Christodoulou; David R Thorburn
Journal:  Med (N Y)       Date:  2020-07-09

2.  ATAD3A variants manifest multisystematically in the brain, nerves, eyes, heart, liver, and skin.

Authors:  Josef Finsterer; Rahim Aliyev
Journal:  Mol Genet Metab Rep       Date:  2020-01-25

3.  ATAD3A has a scaffolding role regulating mitochondria inner membrane structure and protein assembly.

Authors:  Tania Arguello; Susana Peralta; Hana Antonicka; Gabriel Gaidosh; Francisca Diaz; Ya-Ting Tu; Sofia Garcia; Ramin Shiekhattar; Antonio Barrientos; Carlos T Moraes
Journal:  Cell Rep       Date:  2021-12-21       Impact factor: 9.423

4.  ATAD3A mediates activation of RAS-independent mitochondrial ERK1/2 signaling, favoring head and neck cancer development.

Authors:  Liwei Lang; Reid Loveless; Juan Dou; Tiffany Lam; Alex Chen; Fang Wang; Li Sun; Jakeline Juarez; Zhaohui Steve Qin; Nabil F Saba; Chloe Shay; Yong Teng
Journal:  J Exp Clin Cancer Res       Date:  2022-01-29

5.  Severe spinal cord hypoplasia due to a novel ATAD3A compound heterozygous deletion.

Authors:  Tomohiro Ebihara; Taro Nagatomo; Yohei Sugiyama; Tomoko Tsuruoka; Yoshiteru Osone; Masaru Shimura; Makiko Tajika; Keiko Ichimoto; Yuki Naruke; Nana Akiyama; Sze Chern Lim; Yukiko Yatsuka; Kazuhiro R Nitta; Yoshihito Kishita; Takuya Fushimi; Atsuko Okazaki; Akira Ohtake; Yasushi Okazaki; Kei Murayama
Journal:  Mol Genet Metab Rep       Date:  2022-08-24

Review 6.  Emerging Links between Control of Mitochondrial Protein ATAD3A and Cancer.

Authors:  Liwei Lang; Reid Loveless; Yong Teng
Journal:  Int J Mol Sci       Date:  2020-10-25       Impact factor: 5.923

7.  Enhanced cGAS-STING-dependent interferon signaling associated with mutations in ATAD3A.

Authors:  Alice Lepelley; Erika Della Mina; Erika Van Nieuwenhove; Lise Waumans; Sylvie Fraitag; Gillian I Rice; Ashish Dhir; Marie-Louise Frémond; Mathieu P Rodero; Luis Seabra; Edwin Carter; Christine Bodemer; Daniela Buhas; Bert Callewaert; Pascale de Lonlay; Lien De Somer; David A Dyment; Fran Faes; Lucy Grove; Simon Holden; Marie Hully; Manju A Kurian; Hugh J McMillan; Kristin Suetens; Henna Tyynismaa; Stéphanie Chhun; Timothy Wai; Carine Wouters; Brigitte Bader-Meunier; Yanick J Crow
Journal:  J Exp Med       Date:  2021-08-13       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.